{
  "docId": "019dd923-622c-750b-8b98-916758668d1f",
  "docSlug": "34401c2968d1",
  "documentTitle": "Dexcom, Inc. (DXCM)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Ben Axler",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-03-21 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 31,
  "pageCount": 83,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "cite_precedent",
  "function": "cite_precedent",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a 'before-after' or 'comparison' structure to show a trend of industry consolidation/integration.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "comparison_table"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-916758668d1f/31",
  "deckHref": "/decks/019dd923-622c-750b-8b98-916758668d1f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-916758668d1f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-916758668d1f#slide-31",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "This is a clear indication that CGMs are becoming a commoditized component of insulin delivery systems.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-f5d2-7501-bd8a-044ec14c6b92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.91,
        "x": 0.05,
        "y": 0.31
      },
      "kind": "list",
      "text": "Novo Nordisk Partners with Dexcom (October 1, 2018) vs Novo Nordisk Partners with Abbott (February 20, 2019)",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "382dc6f7-7533-4cdf-b6c2-057a44c11cb5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.48,
        "w": 0.91,
        "x": 0.05,
        "y": 0.38
      },
      "kind": "paragraph",
      "text": "Excerpts from press releases detailing the integration of Novo Nordisk insulin pens with Dexcom and Abbott FreeStyle Libre systems.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38e0daad-9335-402d-b5da-00364bd7ce60",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.91,
        "x": 0.05,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "Novo Nordisk, a major player in the diabetes care space, has announced partnerships for its connected insulin pens with both Dexcom (October 2018) and, more recently, Abbott (February 2019). This is a clear indication that CGMs are becoming a commoditized component of insulin delivery systems. Insulin delivery systems – pumps, insulin pens, etc. – are increasingly growing agnostic to the user’s choice of CGM.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "65fc930e-d110-405c-9953-58d1e3eb69e4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Our non-exclusive partnership strategy allows us to integrate with the various digital platforms that people are already using to help manage their diabetes,\" said Camilla Sylvest, executive vice president of Commercial Strategy & Corporate Affairs at Novo Nordisk.",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-f5d2-7501-bd8a-0885fa6b77f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.03,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Source",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7888fcd-6f43-4661-91ba-d5d51a7de6e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.31,
        "y": 0.04
      },
      "kind": "title",
      "text": "Major Players In The Diabetes Device Ecosystem Are Already Moving Towards Wider Compatibility",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77c6c292-85b4-4a29-b262-8f37eb67a7af",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "e4c211e1-e089-416e-bc2d-14a567a98901",
      "evidence": "The slide compares two distinct partnership announcements to support a thesis of industry-wide commoditization.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}